Safety and Immunogenicity in Adults of Revaccination With Adacel Vaccine 10 Years After a Previous Dose.

Trial Profile

Safety and Immunogenicity in Adults of Revaccination With Adacel Vaccine 10 Years After a Previous Dose.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs DTaP vaccine (Primary) ; Diphtheria-tetanus vaccine
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 25 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 08 Sep 2015 Planned End Date changed from 1 Mar 2014 to 1 Oct 2016 as reported by ClinicalTrials.gov.
    • 08 Sep 2015 Planned primary completion date changed to 1 Dec 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top